Arkolith/Insider Trading/SURF/Form 4

Oneill Alison

Chief Medical OfficerSurface Oncology, Inc. (SURF) · full profile →Form 4 · filed Jan 14, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$90K
Net Open-Market Flow
-$90K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2021Sell(S)15K$6.10$90K30K
Mar 1, 2020Grant(A)45K—$045K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-003395) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML